adenosine has been researched along with Intestinal Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acolty, V; Delrée, P; Francois, V; Moser, M; Oldenhove, G; Preyat, N; Shehade, H | 1 |
Antonioli, L; Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M | 1 |
Fukutake, M; Imoto, S; Ishige, A; Miura, N; Miyano, S; Nagasaki, M; Saito, A; Takeda, J; Watanabe, K; Watanabe-Fukuda, Y; Yamaguchi, R; Yamamoto, M | 1 |
Colgan, SP; Eltzschig, HK; Rivera-Nieves, J | 1 |
Colgan, SP; Eltzschig, HK | 1 |
Jackson, EK | 1 |
Hottenstein, OD; Jacobson, ED; Palen, TE; Pawlik, TJ | 1 |
3 review(s) available for adenosine and Intestinal Diseases
Article | Year |
---|---|
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.
Topics: Adenosine; Animals; Humans; Inflammatory Bowel Diseases; Intestinal Diseases; Intestines; Receptors, Purinergic | 2008 |
Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation.
Topics: Adenosine; Animals; Drug Delivery Systems; Humans; Hypoxia-Inducible Factor 1; Inflammation; Intestinal Diseases; Ischemia; Receptor, Adenosine A2B; Signal Transduction | 2009 |
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Extracellular Space; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunity, Mucosal; Inflammation; Intestinal Diseases; Intestinal Mucosa; Irritable Bowel Syndrome; Mice; Nucleotides; Procollagen-Proline Dioxygenase; Receptors, Purinergic P1; Signal Transduction | 2012 |
4 other study(ies) available for adenosine and Intestinal Diseases
Article | Year |
---|---|
Intestinal immunopathology is associated with decreased CD73-generated adenosine during lethal infection.
Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; Disease Models, Animal; Gene Expression; Gene Expression Regulation; Intestinal Diseases; Mice; Mice, Knockout; Receptor, Adenosine A2A; Receptor, Adenosine A2B; T-Lymphocyte Subsets; Toxoplasma; Transforming Growth Factor beta; Tretinoin | 2015 |
Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Alkaloids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Drugs, Chinese Herbal; Female; Gene Expression Profiling; Indomethacin; Intestinal Diseases; Intestine, Small; Mice; Mice, Inbred BALB C | 2009 |
Intraperitoneal administration of adenosine inhibits formation of abdominal adhesions.
Topics: Adenosine; Animals; Disease Models, Animal; Injections, Intraperitoneal; Intestinal Diseases; Intestinal Obstruction; Male; Postoperative Complications; Rats; Rats, Sprague-Dawley; Tissue Adhesions | 2004 |
[Role of adenosine in functional and reactive intestinal hyperemia].
Topics: Adenosine; Animals; Hyperemia; Intestinal Diseases; Rats; Receptors, Purinergic; Splanchnic Circulation | 1991 |